Research article
A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis
1 Centro de Investigacion Clinica de Morelia, Morelia, Virrey de Mendoza 1998-Int. 522 Col Félix Ireta, Mich 58070, Mexico
2 Department of Clinical Immunology/Rheumatology, Academic Medical Center/University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands
3 St Joseph's Hospital, McMaster University, 25 Charlton Avenue East, Hamilton, ON, L8N 1Y2, Canada
4 San Antonio Center for Clinical Research, 8527 Village Drive, San Antonio, TX 78217, USA
5 Revmatologicky ustav, Na Slupi 4, Praha 128 50, Czech Republic
6 Centrum Osteoporozy i Chorób Kostno-Stawowych, Waryńskiego 6/2, 15-461 Białystok, Poland
7 Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
8 Global Development Operations, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
9 Global Biostats and Epidemiology, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
10 Global Development, General Medicine and Inflammation Therapeutic Area, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA
Arthritis Research & Therapy 2010, 12:R192 doi:10.1186/ar3163
Published: 15 October 2010Additional files
Additional file 1:
Investigator site list. Table listing the principal investigators and full study center details.
Format: DOC Size: 296KB Download file
This file can be viewed with: Microsoft Word Viewer
